Fig. 4

The inhibition of each of HAT inhibitors on HBV replication or HAT1 expression. a Relative levels of HBsAg at 72 and 96 h after treatment of HAT inhibitors. b Relative levels of HBV-DNA at 72 and 96 h after treatment of HAT inhibitors. c Relative levels of HBeAg at 72 and 96 h after treatment of HAT inhibitors. d Relative levels of HAT1 mRNA in HepG2.2.15 cells at 72 h after treatment of HAT inhibitors. (*P < 0.05, **P < 0.001, ***P < 0.0001)